Achiko AG (ACHKF)

0.0440 0.0000 (0.00%) At close: 09:30AM EDT

Achiko AG

Tessinerplatz 7
Zurich 8002
Switzerland
41 44 266 67 67
https://www.achiko.com

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 10

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Wern-Yi Goh B.Com., M.B.A.	CEO & Director	240k	N/A	1967
Mr. Lars Birkmann	Chief Financial Officer	N/A	N/A	1978
Mr. Richard Lingard	Sr. VP of Commercialisation	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Achiko AG engages in developing disruptive diagnostic solutions in Indonesia and internationally. The company's lead product is AptameX, a rapid test that uses DNA aptamers instead of antigens to detect the SARS-CoV-2 virus. It also offers Teman Sehat, a mobile check-in and passport application. In addition, the company provides secure payment solutions for game publishers and application developers to accept various payment methods for digital contents and goods under the Mimopay brand, as well as develops game software. Achiko AG was incorporated in 2018 and is headquartered in Zurich, Switzerland.

Corporate governance

Achiko AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.